Pfizer recently announced that its epilepsy drug Lyrica (pregabalin), failed to meet primary endpoint in Phase III study, assessing it as adjunctive therapy in epilepsy patients (aged 5 to 65 years) with primary generalized tonic-clonic (“PGTC”) seizures reports Yahoo...
87 people a day are diagnosed with epilepsy in the United Kingdom (UK)—this equals 600,000 people. With the diagnosis comes other conditions such as the possibility of memory loss and other cognitive issues. A new study led by the University of Liverpool and Alder...
